{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,30]],"date-time":"2025-12-30T08:53:05Z","timestamp":1767084785255,"version":"build-2065373602"},"reference-count":31,"publisher":"MDPI AG","issue":"16","license":[{"start":{"date-parts":[[2024,8,21]],"date-time":"2024-08-21T00:00:00Z","timestamp":1724198400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nutrients"],"abstract":"<jats:p>Fibromyalgia is characterized by chronic widespread pain, fatigue, and sleep disturbances. Recent theories attribute fibromyalgia to central sensitization syndromes, suggesting altered nociceptive processing leads to hyperalgesia and allodynia. Standardized effective treatments are currently lacking. Palmitoylethanolamide and melatonin have shown pain-relieving effects in chronic pain conditions, including fibromyalgia, with excellent safety. Our open-label study assessed the impact of a daily combination of 1200 mg of palmitoylethanolamide and 0.2 mg of melatonin on pain, sleep, and quality of life in fibromyalgia patients. Between June 2023 and March 2024, 50 patients (2016 ACR criteria) were treated and evaluated at baseline, 1 month, 3 months, and 4 months (1 month discontinuation). The assessments included VAS for pain, ISI for insomnia, HAQ for health assessments, and a tender points evaluation. The patients, averaging 54.12 years old with a 3:1 female-to-male ratio, showed significant improvements in VAS, ISI, and HAQ scores relative to their own baselines and a reduction in tender points at 1 and 3 months, which was maintained at 4 months. No adverse events were reported. This study is the first to demonstrate the efficacy of a palmitoylethanolamide and melatonin combination as an adjunct therapy in fibromyalgia, highlighting its potential to reduce pain and improve sleep and quality of life.<\/jats:p>","DOI":"10.3390\/nu16162785","type":"journal-article","created":{"date-parts":[[2024,8,22]],"date-time":"2024-08-22T04:26:57Z","timestamp":1724300817000},"page":"2785","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["A Fixed Combination of Palmitoylethanolamide and Melatonin (PEATONIDE) for the Management of Pain, Sleep, and Disability in Patients with Fibromyalgia: A Pilot Study"],"prefix":"10.3390","volume":"16","author":[{"given":"Riccardo","family":"Terribili","sequence":"first","affiliation":[{"name":"Rheumatology Department, Siena University Hospital, Viale Mario Bracci 16, 53100 Siena, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1689-2341","authenticated-orcid":false,"given":"Giulia","family":"Vallifuoco","sequence":"additional","affiliation":[{"name":"Rheumatology Department, Siena University Hospital, Viale Mario Bracci 16, 53100 Siena, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marco","family":"Bardelli","sequence":"additional","affiliation":[{"name":"Rheumatology Department, Siena University Hospital, Viale Mario Bracci 16, 53100 Siena, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bruno","family":"Frediani","sequence":"additional","affiliation":[{"name":"Rheumatology Department, Siena University Hospital, Viale Mario Bracci 16, 53100 Siena, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6658-1037","authenticated-orcid":false,"given":"Stefano","family":"Gentileschi","sequence":"additional","affiliation":[{"name":"Rheumatology Department, Siena University Hospital, Viale Mario Bracci 16, 53100 Siena, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2024,8,21]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1038\/s41584-020-00506-w","article-title":"Fibromyalgia: An update on clinical characteristics, aetiopathogenesis and treatment","volume":"16","author":"Giorgi","year":"2020","journal-title":"Nat. Rev. Rheumatol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.medcli.2017.06.008","article-title":"Fibromyalgia: Prevalence, epidemiologic profiles and economic costs","volume":"149","year":"2017","journal-title":"Med. Clin."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11916-013-0356-5","article-title":"Worldwide epidemiology of fibromyalgia topical collection on fibromyalgia","volume":"17","author":"Queiroz","year":"2013","journal-title":"Curr. Pain. Headache Rep."},{"key":"ref_4","first-page":"446","article-title":"Fibromyalgia and Its Consequent Disability","volume":"22","author":"Tanai","year":"2020","journal-title":"IMAJ Isr. Med. Assoc. J."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1002\/art.1780330203","article-title":"The American College of Rheumatology 1990 Criteria for the Classification of Fibromyalgia: Report of the Multicenter Criteria Committee","volume":"33","author":"Wolfe","year":"1990","journal-title":"Arthritis Rheumatol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1002\/acr.20140","article-title":"The American College of Rheumatology preliminary diagnostic criteria for fibromyalgia and measurement of symptom severity","volume":"62","author":"Wolfe","year":"2010","journal-title":"Arthritis Care Res."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1990","DOI":"10.1111\/imj.15430","article-title":"Central sensitivity and fibromyalgia","volume":"51","author":"Mezhov","year":"2021","journal-title":"Intern. Med. J."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"131","DOI":"10.2174\/1573397111666150619095007","article-title":"Fibromyalgia: The Prototypical Central Sensitivity Syndrome","volume":"11","author":"Boomershine","year":"2015","journal-title":"Curr. Rheumatol. Rev."},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Theoharides, T.C., Tsilioni, I., and Bawazeer, M. (2019). Mast Cells, Neuroinflammation and Pain in Fibromyalgia Syndrome. Front. Cell. Neurosci., 13.","DOI":"10.3389\/fncel.2019.00353"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.bbi.2018.09.018","article-title":"Brain glial activation in fibromyalgia-a multi-site positron emission tomography investigation","volume":"75","author":"Albrecht","year":"2019","journal-title":"Brain Behav. Immun."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1582432","DOI":"10.1155\/2022\/1582432","article-title":"Oxidative Stress in Fibromyalgia: From Pathology to Treatment","volume":"2022","author":"Assavarittirong","year":"2022","journal-title":"Oxid. Med. Cell. Longev."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1038\/nm.2234","article-title":"Interactions between the immune and nervous systems in pain","volume":"16","author":"Ren","year":"2010","journal-title":"Nat. Med."},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"\u00dabeda-D\u2019ocasar, E., D\u00edaz-Benito, V.J., Gallego-Sendarrubias, G.M., Valera-Calero, J.A., Vicario-Merino, \u00c1., and Herv\u00e1s-P\u00e9rez, J.P. (2020). diagnostics Pain and Cortisol in Patients with Fibromyalgia: Systematic Review and Meta-Analysis. Diagnostics, 10.","DOI":"10.3390\/diagnostics10110922"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"S11","DOI":"10.1002\/hup.1029","article-title":"Fibromyalgia\u2014pathways and neurotransmitters","volume":"24","author":"Stahl","year":"2009","journal-title":"Hum. Psychopharmacol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1136\/annrheumdis-2016-209724","article-title":"EULAR revised recommendations for the management of fibromyalgia","volume":"76","author":"Macfarlane","year":"2017","journal-title":"Ann. Rheum. Dis."},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Rankin, L., and Fowler, C.J. (2020). The Basal Pharmacology of Palmitoylethanolamide. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21217942"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"C145","DOI":"10.1007\/BF01972748","article-title":"A proposed autacoid mechanism controlling mastocyte behaviour","volume":"39","author":"Aloe","year":"1993","journal-title":"Agents Actions"},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Lang-Illievich, K., Klivinyi, C., Rumpold-Seitlinger, G., Dorn, C., and Bornemann-Cimenti, H. (2022). The Effect of Palmitoylethanolamide on Pain Intensity, Central and Peripheral Sensitization, and Pain Modulation in Healthy Volunteers\u2014A Randomized, Double-Blinded, Placebo-Controlled Crossover Trial. Nutrients, 14.","DOI":"10.3390\/nu14194084"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"167","DOI":"10.2174\/157015912800604489","article-title":"Melatonin in Antinociception: Its Therapeutic Applications","volume":"10","author":"Srinivasan","year":"2012","journal-title":"Curr. Neuropharmacol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/BF03168221","article-title":"Physiological and metabolic functions of melatonin","volume":"60","author":"Barrenetxe","year":"2004","journal-title":"J. Physiol. Biochem."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1038\/s41386-019-0439-z","article-title":"Sleep deficiency and chronic pain: Potential underlying mechanisms and clinical implications","volume":"45","author":"Haack","year":"2020","journal-title":"Neuropsychopharmacology"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/S0304-3959(96)03226-5","article-title":"Sequential daily relations of sleep, pain intensity, and attention to pain among women with fibromyalgia","volume":"68","author":"Affleck","year":"1996","journal-title":"Pain"},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"D\u2019amico, R., Impellizzeri, D., Cuzzocrea, S., and Di Paola, R. (2020). ALIAmides Update: Palmitoylethanolamide and Its Formulations on Management of Peripheral Neuropathic Pain. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21155330"},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Scuteri, D., Guida, F., Boccella, S., Palazzo, E., Maione, S., Rodr\u00edguez-Landa, J.F., Mart\u00ednez-Mota, L., Tonin, P., Bagetta, G., and Corasaniti, M.T. (2022). Effects of Palmitoylethanolamide (PEA) on Nociceptive, Musculoskeletal and Neuropathic Pain: Systematic Review and Meta-Analysis of Clinical Evidence. Pharmaceutics, 14.","DOI":"10.3390\/pharmaceutics14081672"},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Lang-Illievich, K., Klivinyi, C., Lasser, C., Brenna, C.T.A., Szilagyi, I.S., and Bornemann-Cimenti, H. (2023). Palmitoylethanolamide in the Treatment of Chronic Pain: A Systematic Review and Meta-Analysis of Double-Blind Randomized Controlled Trials. Nutrients, 15.","DOI":"10.3390\/nu15061350"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1007\/s40122-015-0038-6","article-title":"Palmitoylethanolamide in Fibromyalgia: Results from Prospective and Retrospective Observational Studies","volume":"4","author":"Skaper","year":"2015","journal-title":"Pain Ther."},{"key":"ref_27","first-page":"1323","article-title":"Palmitoylethanolamide and acetyl-L-carnitine act synergistically with duloxetine and pregabalin in fibromyalgia: Results of a randomised controlled study","volume":"41","author":"Salaffi","year":"2023","journal-title":"Clin. Exp. Rheumatol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"101072","DOI":"10.1016\/j.ctcp.2019.101072","article-title":"Melatonin in the treatment of fibromyalgia symptoms: A systematic review","volume":"38","author":"Hemati","year":"2020","journal-title":"Complement. Ther. Clin. Pract."},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Gonz\u00e1lez-Flores, D., L\u00f3pez-Pingarr\u00f3n, L., Casta\u00f1o, M.Y., G\u00f3mez, M., Rodr\u00edguez, A.B., Garc\u00eda, J.J., and Garrido, M. (2023). Melatonin as a Coadjuvant in the Treatment of Patients with Fibromyalgia. Biomedicines, 11.","DOI":"10.3390\/biomedicines11071964"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.semarthrit.2016.08.012","article-title":"2016 Revisions to the 2010\/2011 fibromyalgia diagnostic criteria","volume":"46","author":"Wolfe","year":"2016","journal-title":"Semin. Arthritis Rheum."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.phrs.2009.11.014","article-title":"Evidence of melatonin synthesis and release by mast cells. Possible modulatory role on inflammation","volume":"62","author":"Maldonado","year":"2010","journal-title":"Pharmacol. Res."}],"container-title":["Nutrients"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6643\/16\/16\/2785\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T15:40:13Z","timestamp":1760110813000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6643\/16\/16\/2785"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,21]]},"references-count":31,"journal-issue":{"issue":"16","published-online":{"date-parts":[[2024,8]]}},"alternative-id":["nu16162785"],"URL":"https:\/\/doi.org\/10.3390\/nu16162785","relation":{},"ISSN":["2072-6643"],"issn-type":[{"type":"electronic","value":"2072-6643"}],"subject":[],"published":{"date-parts":[[2024,8,21]]}}}